ImmunityBio, Inc. (IBRX): Weighted Average Diluted Shares
919.86M
Year ended 2025-12-31
+32.0%
3-year compound annual growth
+19.5%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 919.86M | +31.3% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | 700.44M | +37.7% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | 508.64M | +27.2% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | 399.90M | +2.7% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | 389.23M | +3.2% | 2024-03-19, From 2021-01-01 |
| 2020-12-31 | 377.07M | +2.9% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | 366.32M | n/a | 2022-03-01, From 2019-01-01 |